1-3 of 3
Guido Tricot
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up

Clinical Trials & Observations
Samer Al Hadidi, Obada Ehab Ababneh, Carolina D. Schinke, Sharmilan Thanendrarajan, Clyde Bailey, Robert Smith, Susan Panozzo, Daisy Alapat, Michele Cottler-Fox, Guido Tricot, John D. Shaughnessy, Jr., Fenghuang Zhan, Jeffrey Sawyer, Bart Barlogie, Maurizio Zangari, Frits van Rhee
Journal: Blood Advances
Blood Adv (2024) 8 (3): 703–707.
https://doi.org/10.1182/bloodadvances.2023011601
Published: 2024
Includes: Supplemental data
Journal Articles

Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS

Clinical Trials & Observations
Wancheng Guo, Anne Zhan, David E. Mery, Manit N. Munshi, Oussama Makhoul, Clyde Baily, Maurizio Zangari, Guido Tricot, Hongling Peng, John D. Shaughnessy, Jr.
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6676–6684.
https://doi.org/10.1182/bloodadvances.2023011096
Published: 2023
Includes: Supplemental data
Journal Articles

Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma

Clinical Trials & Observations
Meera Mohan, Samantha Kendrick, Aniko Szabo, Naveen Yarlagadda, Dinesh Atwal, Yadav Pandey, Arya Roy, Richa Parikh, James Lopez, Sharmilan Thanendrarajan, Carolina Schinke, Daisy Alapat, Jeffrey Sawyer, Erming Tian, Guido Tricot, Frits van Rhee, Maurizio Zangari
Journal: Blood Advances
Blood Adv (2022) 6 (3): 808–817.
https://doi.org/10.1182/bloodadvances.2021005822
Published: 2022
Includes: Supplemental data